Unsupported browser

You are using an outdated browser. Please upgrade your browser to improve your experience.

Sign up for an Award

Participate with your entry in one of our professional or student awards.

Sign up for an award

Sign up for a Profile

Create your own profile and publish it in the iF WORLD DESIGN GUIDE.

Sign up for a profile

Learn more:

iF SOCIAL IMPACT PRIZE

Present your project for free and win your share of EUR 50,000 in prize money.

Publish your project

Hepatus Series / Non invasive & Fibrosis Evaluation System

Hepatus Series
Hepatus Series

Discipline: User Interface (UI)

Qualified
for the Final Jury

Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series

Discipline: User Interface (UI)

Qualified
for the Final Jury

Hepatus series with wide clinical applications build a new era for non-invasive liver disease diagnosis. It is suitable for the quantitative diagnosis of liver fibrosis and fatty liver caused by various chronic liver diseases. It is conducive to the early detection, diagnosis, treatment and rehabilitation of various chronic liver diseases. Recommend by global liver disease guidelines, non-invasive quantitative of fibrosis is the first choice for chronic liver disease assessment.

  • DATE OF LAUNCH 2020

  • DEVELOPMENT TIME 25 - 36 months

  • TARGET REGIONS Asia, Europe, North America, South America

  • TARGET GROUPS Consumer / User

Client / Manufacturer

Shenzhen Mindray Biomedical Electronics Co. LTD

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, China

Go to profile
Design

Shenzhen Mindray Biomedical Electronics Co. LTD

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, China

Bo Huang, Jinzhou Zhao, Linghui Kuang, Xiang Zhou

Go to profile